Physician

Janna Kate Nunez-Gussman, M.D.

According to 2025 Medicare claims, Janna Nunez-Gussman, M.D. (NPI: 1831215094) practices dermatology in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is W EDWARD COLLINS MD PA (NPI: 1043458672; TIN: 263960741) and primary practice location at 77701-4688.

Nunez-Gussman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 682 traditional Medicare patients, billed 3,628 HCPCS/CPT codes, and received $296,544 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 581 prescription claims across 339 beneficiaries totaling $67,594 in drug costs, led by Fluorouracil (Fluorouracil). 2017 DME data shows 18 claims. Open Payments data shows 24 records totaling $1,445. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $35,482 to $67,594. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	671	4,271	$277,304
2016	695	4,310	$280,569
2017	682	4,259	$282,621
2018	687	3,995	$270,623
2019	687	3,942	$271,709
2020	655	3,580	$257,476
2021	634	3,886	$256,067
2022	695	3,801	$249,985
2023	701	3,498	$251,183
2024	682	3,628	$296,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	235	450	$35,482
2016	254	499	$41,019
2017	264	516	$33,184
2018	302	572	$21,948
2019	275	492	$21,011
2020	272	483	$50,567
2021	298	599	$55,997
2022	306	534	$85,679
2023	285	511	$48,200
2024	339	581	$67,594

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	18	$1,982
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	186	238	$209
17110	Destruction of skin growth, 1-14 growths	135	151	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	397	521	$58
17000	Destruction of precancer skin growth, 1 growth	238	330	$34
17003	Destruction of precancer skin growth, 2-14 growths	176	1,142	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	33	1,175	$2,210
Clobetasol Propionate	Clobetasol Propionate	33	1,337	$2,119
Cephalexin	Cephalexin	168	1,769	$808
Triamcinolone Acetonide	Triamcinolone Acetonide	51	1,542	$773
Ketoconazole	Ketoconazole	22	763	$518

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$1,445	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Janna Kate Nunez-Gussman, M.D.?

Tedicare shows public-source Medicare data for Janna Kate Nunez-Gussman, M.D. (NPI 1831215094), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Janna Kate Nunez-Gussman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Janna Kate Nunez-Gussman, M.D.?

Janna Kate Nunez-Gussman, M.D. is linked to W EDWARD COLLINS MD PA (billing NPI 1043458672) in the available physician profile data.

Does Janna Kate Nunez-Gussman, M.D. have Open Payments data?

Janna Kate Nunez-Gussman, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.